About us Contacts Interactions: 118 620
Drug search by name

Reserpine, hydralazine, and hydrochlorothiazide and Coronary artery disease

Result of checking the interaction of drug Reserpine, hydralazine, and hydrochlorothiazide and disease Coronary artery disease for safety when used together.

Check result:
Reserpine, hydralazine, and hydrochlorothiazide <> Coronary artery disease
Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

The use of hydralazine is contraindicated in patients with coronary artery disease. Reflex tachycardia may commonly occur. Palpitations and chest pain have also been reported. Myocardial infarction has been associated with the use of hydralazine.

References:
  • Packer M, Meller J, Medina N, et al "Provocation of myocardial ischemic events during initiation of vasodilator therapy for severe chronic heart failure." Am J Cardiol 48 (1981): 939-46
  • Laslett LJ, DeMaria AN, Amsterdam EA, Mason DT "Hydralazine-induced tachycardia and sodium retention in heart failure: hemodynamic and symptomatic correlation by prazosin therapy." Arch Intern Med 138 (1978): 819-20
  • Koch-Weser J "Hydralazine." N Engl J Med 295 (1976): 320-3
Reserpine, hydralazine, and hydrochlorothiazide

Generic Name: hydralazine / hydrochlorothiazide / reserpine

Brand Name:

Synonyms: Reserpine, hydralazine, and hydrochlorothiazide (Oral)